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Background: This study aims to validate and evaluate the psychometric properties and
measurement invariance of the Italian version of the European Organization for Research
and Treatment of Cancer (EORTC) Quality of Life Questionnaire-Core 30 (QLQ-C30),
which is a measure of quality of life (QoL) for lung cancer patients after surgery.
Methods: A total of 167 lung cancer patients completed the Italian version of the
EORTC QLQ-C30 questionnaire at 30 days after they received a lobectomy. The factor
structure of this scale was assessed by performing confirmatory factor analysis (CFA).
Measurement invariance was evaluated by considering differential item functioning (DIF)
due to age, gender, and type of surgery (i.e., robot- or not robot-assisted).
Results: The CFA demonstrated the validity of the factor structure of the EORTC
QLQ-C30 in assessing overall health and eight distinct subscales of adverse events
and functioning. Moreover, the results highlighted a minimal DIF with only trivial
consequences on measurement invariance. Specifically, the DIF did not affect the mean
differences of latent scores of QoL between patients undergoing robot-assisted surgery
or traditional surgery.
Conclusion: These findings supported the validity and suitability of the EORTC QLQ-
C30 for the assessment of QoL in lung cancer patients of diverse ages and genders
undergoing lobectomy with or without robot-assisted surgery.
Keywords: lung cancer, EORTC QLQ-C30, quality of life, validity, assessment, measurement invariance
Abbreviations: CFA, confirmatory factor analysis; CFI, comparative fit index; DIF, differential item functioning; EORTC
QLQ-C30, European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire-Core 30
(QLQ-C30); MCFA, multiple-group factor analysis; MIMIC, multiple indicators–multiple causes; MLR, robust maximum
likelihood; PCLOSE, probability of close fit; QoL, quality of life; RMSEA, root mean square error of approximation; SRMR,
standardized root mean square residual; TLI, tucker–lewis index.
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INTRODUCTION
Patient reported outcomes (PROs) have become important
factors in cancer care to measure the patient’s perception of
the health status, including treatment side effects, functional
impairments, and health-related QoL (U.S. Department of Health
and Human Services FDA Center for Drug Evaluation and
Research et al., 2006; Mercieca-Bebber et al., 2018). Through
the QoL assessment, it would be possible to obtain a more
complete framework of the medical condition, especially for
diseases requiring long-term care services. Among the large
amount of developed instruments to evaluate patient well-being,
the EORTC QLQ-C30 is the most used tool for assessing QoL in
cancer-specific patients (Iravani et al., 2018). The EORTC QLQ-
C30 consists of 30 self-reported questions assessing different
aspects of patient functioning, global health status, and cancer-
related symptoms. More specifically, it is composed of five multi-
item functional scales (role, physical, cognitive, emotional, and
social functioning), three multi-item symptom scales (fatigue,
pain, and nausea and vomiting), individual items concerning
common symptoms in cancer patients (dyspnea, insomnia,
appetite loss, constipation, diarrhea, and financial difficulties),
and two questions assessing overall QoL. All of the multi-item
scales and single-item measures range in a score from 0 to
100, where a high score represents a higher response level.
Thus, a high score for a functional scale implicates a healthy
level of functioning, while a high score for a symptom scale
represents a worse level of symptoms (Aaronson et al., 1993).
The EORTC QLQ-C30 has been translated in over 110 languages
and validated in many countries in different samples of cancer
patients (Bjordal et al., 2000; EORTC Quality of Life Group,
2019). According to a cross-cultural project on a large and
heterogeneous sample, the EORTC QoL Group reported robust
measurement properties across various countries and languages
(Scott et al., 2006, 2007). In Italy, the questionnaire has been
validated only in breast and colon cancer patients (Apolone
et al., 1998; Mosconi et al., 2002; Winters et al., 2014). At
the same time, other authors investigated the applicability of
the EORTC QLQ-C30 structure, and positively demonstrated
its invariance across different cancer sites (Costa et al., 2015).
Despite these psychometric properties, few scientific articles
performed factor analysis for validating this tool in lung
cancer patients, a clinical area in which the EORTC QLQ-
C30 is the most used instrument to report patient well-
being through the different phases of disease (Damm et al.,
2013). To our knowledge, no published articles investigated
the psychometric properties and the measurement invariance
of the Italian version of the EORTC QLQ-C30 in lung cancer
patients. In fact, only four studies measured QoL in Italian
lung cancer patients through the administration of the EORTC
QLQ-C30. Two of them were international studies and involved
several countries, with all of them focusing on non-small
cell lung cancer (Di Maio et al., 2004; Maione et al., 2005;
Koller et al., 2017; Wood et al., 2019).
The purpose of the current study was to evaluate the factor
structure proposed by Costa et al. (2015) for the EORTC
QLQ-C30 in a sample of postoperative lung cancer patients
who underwent lobectomy surgery. Moreover, its measurement
invariance across patients of varying age, gender, and undergoing
robotic or traditional surgery was also evaluated. The testing of
measurement invariance is a necessary step to further evaluate
any inter-individual differences.
MATERIALS AND METHODS
Participants and Procedure
An Italian sample of 167 patients with lung cancer who were
also undergoing lobectomy were recruited for the value-based
project1 at the European Institute of Oncology in Milan
between October 2015 and October 2017. Patients were
included in the study if they: (1) were diagnosed with lung
cancer, (2) were native Italian speakers, (3) referred to the
value-based project, and (4) did not have neurological or
psychopathological problems. They completed the EORTC
QLQ-C30 after 30 days from surgery (Aaronson et al., 1993;
Apolone et al., 1998). During the doctor’s post-operative visit,
a trained nurse distributed the questionnaire to the patients
and they completed it using paper and pencil. Informed
consent was provided and signed by each participant.
Participation in the study was voluntary and at each
moment, patients could withdraw their consent. The study
was developed in accordance with the principles stated in
the Declaration of Helsinki (59th WMA General Assembly,
Seoul, 2008) and was approved by the European Institute of
Oncology Ethical Committee at the European Institute of
Oncology, Milan, Italy.
Statistical Analysis
All statistical analyses were performed using the maximum
likelihood with robust standard errors (MLR) estimation
method with Mplus 8.2 (Muthen and Muthén, 2017). The
MLR estimator is robust to strong departures from univariate
and multivariate normality of observed variables. The EORTC
QLQ-C30 comprises nine multiple-item dimensions and
six single items. In a first step, the proposed model for the
EORTC QLQ-C30 was assessed through CFA. Specifically, as
reported in Figure 1, the measurement model included the
nine multiple item dimensions of physical functioning (five
items), role functioning (two items), emotional functioning
(four items), social functioning (two items), cognitive
functioning (two items), pain (two items), fatigue (three
items), nausea and vomiting (two items), and overall health
and QoL (two items). Following Costa et al. (2015), the six
single-item dimensions (i.e., dyspnea, insomnia, appetite
loss, constipation, diarrhea, and financial difficulties) were
omitted from the tested model. For ease of interpretation,
the covariances among latent dimensions of QoL were
1The value-based project is a multidisciplinary project where medical, economical,
and psychological outcomes are collected through standardized questionnaires
at different time points consistently with patient’s recovery and follow ups. The
aim of this project is to create predictive models of care pathways of the major
cancer diagnosis.
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FIGURE 1 | The measurement model for the EORTC QLQ-C30. For ease of interpretation, covariances among latent factors are not reported but estimated in the
CFA model.
not reported in the figure, but they were all estimated
in the analyses.
Model fit was assessed by considering five main fit indices.
Specifically, a good-fitting model was indicated by a non-
significant χ2, a RMSEA below 0.06, a SRMR <0.80, a CFI,
and a TLI >0.90 (Hu and Bentler, 1999). Moreover, the 90%
confidence interval for RMSEA was considered to test the null
hypothesis of poor model fit. Specifically, a good-fitting model
was indicated by the upper limit <0.08 and the lower limit
close to zero. Finally, we considered the PCLOSE as well, a one-
sided test of the null hypothesis that the model has a close fit
(i.e., RMSEA equals 0.05). P-value >0.50 indicated a good-fitting
model (Jöreskog and Sörbom, 1996).
Then, measurement invariance was evaluated by considering
DIF. DIF is a prerequisite for a valid and meaningful comparison
of levels of QoL across gender, age, and type of surgery (robot-
assisted vs. traditional surgery). Specifically, a MIMIC was
performed to assess differences in the measurement model due
to age, gender, and type of surgery. A MIMIC model was
performed because it has specific advantages over multiple-
group CFA (MCFA) in evaluating measurement invariance.
Specifically, compared to MCFA, the MIMIC model permits
to: assess differences in the measurement model due to several
confounding variables; simultaneously evaluate the role of
dichotomous (i.e., robot-assisted vs. not robot-assisted surgery
and gender) and continuous variables (i.e., age); include
directly in the model continuous variables without median-
splitting, mean-splitting, or subjective categorization; and test
measurement invariance even with small sample size. Thus,
mainly because of the low sample size, we preferred the MIMIC
model over the MCFA to assess the structural invariance of
the EORTC QLQ-C30. In the last decade, MIMIC model
had been adopted to validly test measurement invariance
of self-report measure of QoL in asthma (Mora et al.,
2009) and pediatric patients (Stevanovic et al., 2016), life
satisfaction (Jang et al., 2017), dispositional optimism (Steca
et al., 2017), protective behavioral strategies (Treloar et al.,
2014), adolescent burnout (Li et al., 2013), and depression
(Skule et al., 2014).
The MIMIC model included the measurement model (i.e.,
the EORTC QLQ-C30 factor structure) plus a structural model
assessing DIF. This structural model estimated the effect of
covariates of gender, age, and type of surgery on latent
dimensions of QoL and, thus, evaluated differences in these latent
factors due to the three considered covariates. The structural
model included the direct effects of these three covariates
on items as well. In a first step, these direct effects fixed at
zero. Then, modification indices were examined to ascertain
whether the estimation of any of these direct effects would
improve model fit. Estimation of direct effects was performed
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with a stepwise approach: the constraint that resulted in the
greatest change of χ2 (i.e., highest value of the modification
index) were firstly estimated. We then continued at freely
estimating one direct effect at time until any modification was
relevant (i.e., 1χ2 > 3.84). Each significant direct effect was
interpreted as an indication of DIF: the likelihood to endorse
an item was conditional to the specific covariate involved
in the direct effect. For example, if the direct effect of age
on item 1 was significant and positive, then the likelihood
of endorsing this item differed between patients of different
age and, specifically, younger people had lower chance to
endorse this item. Thus, measurement invariance may be
strongly impaired when high degree of DIF is ascertained.
Age was treated as a continuous variable, whereas gender
(i.e., male = 0; female = 1) and type of surgery (i.e., not
robot-assisted surgery = 0; robot-assisted surgery = 1) were
binary variables.
RESULTS
Sample and Item Characteristics
Participants had a mean age of 66.69 ± 7.70 and 100 (59.9%)
of them were males. The sample underwent lobectomy surgical
procedure (N = 54; 32.3% with robot-assisted surgery; N = 113;
67.7% with not robot-assisted surgery). Other clinical variables
are reported in Table 1.
Descriptive statistics of item response (mean, standard
deviation, and minimum and maximum) are reported in Table 2.
Assessing the Factor Structure
The proposed measurement model for the EORTC QLQ-C30
showed a good fit [χ2(216, N = 167) = 301.48; RMSEA = 0.05;
90% CI of RMSEA = 0.04–0.06; PCLOSE = 0.555; CFI = 0.95;
TLI = 0.93; SRMR = 0.05]. The standardized loadings are
displayed in Table 3. As reported, all the items had significant
loadings and high loadings ranging from 0.36 to 1.08, except for
i5 (λ = 0.17; SE = 0.07; p < 0.05) and i15 (λ = 0.13; SE = 0.12;
p > 0.05). Specifically, while high scores of pain, fatigue, nausea
and vomiting, and physical, role, cognitive, emotional, and social
TABLE 1 | Clinical sample characteristics.
Sample (%)
ASA class
1 3.6
2–3 96.4
Charlson index
<1 60.5
≥1 39.5
Robot-assisted surgery
No 26.4
Yes 55.9
Complications
No 67.1
Yes 32.9
functioning indicated high levels of impairment, high values of
overall health and QoL denoted high levels of health-related QoL.
Table 4 displays correlations among the nine latent
dimensions of QoL. Significant correlation coefficients ranged
from 0.24 to 0.85 in absolute values. These correlations could
be interpreted as measure of effect size of the associations
among latent factors. Following suggestion by Cohen (1988),
the magnitude of these coefficients was interpreted as: weak
(>0.10), moderate (>0.30), and strong (>0.50). Specifically,
weak associations were reported between cognitive functioning
and physical functioning (r = 0.29), emotional functioning
and nausea/vomiting (r = 0.29), and nausea/vomiting and
health-related QoL (r = −0.24). A grand total of 18 correlations
were large in magnitude. Physical functioning and fatigue
were the latent dimensions displaying the higher number of
strong correlations with other factors of QoL. Specifically,
physical functioning displayed strong associations with pain
(r = 0.54), fatigue (r = 0.85), health-related QoL (r = −0.67), role
(r = 0.77), cognitive (r = 0.51), emotional (r = 0.50), and social
functioning (r = 0.50). Fatigue showed strong associations with
health-related QoL (r = −0.68), pain (r = 0.63), nausea/vomiting
(r = 0.51), physical (r = 0.85), role (r = 0.76), cognitive (r = 0.59),
emotional (r = 0.62), and social functioning (r = 0.51). Finally,
role functioning was the latent dimension of QoL most strongly
associated with health-related QoL (r =−0.72).
MIMIC Analysis of Measurement
Invariance
After entering age, gender, and type of surgery in the model,
goodness of fit slightly remained substantially unchanged
[χ2(261, N = 167) = 385.65; RMSEA = 0.05; 90% CI of
RMSEA = 0.04–0.06; PCLOSE = 0.299; CFI = 0.93; TLI = 0.91;
SRMR = 0.05]. The standardize factor loadings ranged from 0.15
to 1.01. Some significant influences of the three covariates on
latent factors of QoL were reported. Specifically, type of surgery
was responsible for differences in nausea/vomiting (β = −0.52;
SE = 0.22; p < 0.05), pain (β = −0.32; SE = 0.15; p < 0.05),
and physical (β = −0.39; SE = 0.15; p < 0.01), role (β = −0.46;
SE = 0.16; p < 0.01), cognitive (β = −0.31; SE = 0.15; p < 0.05),
and social functioning (β =−0.36; SE = 0.15; p < 0.05).
The inspection of modification indices suggested that model
fit would be improved by freely estimated the direct effect of
age on item 1 (β = −0.03; SE = 0.01; p < 0.001). After the
estimation of this effect, the model still showed a good fit [χ2(260,
N = 167) = 368.42; RMSEA = 0.05; 90% CI of RMSEA = 0.04–
0.06; PCLOSE = 0.491; CFI = 0.94; TLI = 0.92; SRMR = 0.05]. No
other modification indices were relevant.
After controlling for this DIF, some significant influences of
the three covariates on latent factors of QoL were reported.
Specifically, these influences were the same as the ones reported
in the previous MIMIC model (i.e., the model not freely
estimating direct effects of covariates on items). Specifically, type
of surgery was responsible for differences in nausea/vomiting
(β = −0.52; SE = 0.22; p < 0.05), pain (β = −0.32; SE = 0.15;
p < 0.05), and physical (β = −0.38; SE = 0.15; p < 0.01), role
(β = −0.46; SE = 0.16; p < 0.01), cognitive (β = −0.31; SE = 0.15;
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TABLE 2 | Descriptive statistics of item response.
Items M SD Min Max
i1. Do you have any trouble doing strenuous activities, like carrying a heavy shopping bag or a suitcase? 2.16 0.85 1 4
Ha difficoltà nel fare lavori faticosi, come sollevare una borsa della spesa pesante o una valigia?
i2. Do you have any trouble taking a long walk? 2.171 0.87 1 4
Ha difficoltà nel fare una lunga passeggiata?
i3. Do you have any trouble taking a short walk outside of the house? 1.396 0.68 1 4
Ha difficoltà nel fare una breve passeggiata fuori casa?
i4. Do you need to stay in bed or a chair during the day? 1.799 0.76 1 4
Ha bisogno di stare a letto o su una sedia durante il giorno?
i5. Do you need help with eating, dressing, washing yourself, or using the toilet? 1.085 0.37 1 4
Ha bisogno di aiuto per mangiare, vestirsi, lavarsi, o andare in bagno?
i6. Were you limited in doing either your work or other daily activities? 1.915 0.84 1 4
Ha avuto limitazioni nel fare il Suo lavoro o i lavori di casa?
i7. Were you limited in pursuing your hobbies or other leisure time activities? 1.857 0.82 1 4
Ha avuto limitazioni nel praticare i Suoi passatempi- hobby o altre attività di divertimento o svago?
i9. Have you had pain? 1.883 0.85 1 4
Ha avuto dolore?
i10. Did you need to rest? 2.085 0.73 1 4
Ha avuto bisogno di riposo?
i12. Have you felt weak? 2.037 0.81 1 4
Si è sentito debole?
i14. Have you felt nauseated 1.421 0.69 1 4
Ha avuto un senso di nausea?
i15. Have you vomited? 1.049 0.29 1 4
Ha vomitato?
i18. Were you tired? 2.078 0.74 1 4
Si è sentito stanco?
i19. Did pain interfere with your daily activities? 1.723 0.79 1 4
Il dolore ha interferito con le Sue attività quotidiane?
i20. Have you had difficulty in concentrating on things, like reading a newspaper or watching television? 1.265 0.56 1 4
Ha avuto difficoltà a concentrarsi su cose come leggere un giornale o guardare la televisione?
i21. Did you feel tense? 1.719 0.74 1 4
Si è sentito teso?
i22. Did you worry? 1.768 0.79 1 4
Si è preoccupato?
i23. Did you feel irritable? 1.643 0.74 1 4
Si è sentito irritabile?
i24. Did you feel depressed? 1.675 0.86 1 4
Si è sentito depresso?
i25. Have you had difficulty remembering things? 1.394 0.63 1 4
Ha avuto difficoltà a ricordare le cose?
i26. Has your physical condition or medical treatment interfered with your family life? 1.429 0.65 1 4
Le Sue condizioni fisiche o il Suo trattamento medico hanno interferito con la Sua vita familiare?
i27. Has your physical condition or medical treatment interfered with your social activities? 1.582 0.73 1 4
Le Sue condizioni fisiche o il Suo trattamento medico hanno interferito con le Sue attività sociali?
i29. How would you rate your overall health during the past week? 4.597 1.03 2 7
Come valuterebbe in generale la Sua salute durante gli ultimi sette giorni?
i30. How would you rate your overall quality of life during the past week? 4.636 1.14 2 7
Come valuterebbe in generale la Sua qualità di vita durante gli ultimi sette giorni?
p< 0.05), and social functioning (β =−0.36; SE = 0.15; p< 0.05).
The only exception was that age directly influenced physical
functioning (β = 0.03; SE = 0.01; p < 0.01). Thus, by comparing
this final model with the previous one we may conclude that any
bias due to DIF is only minimal and not accounting for DIF it
may have only trivial consequences for the assessment of physical
functioning (i.e., the magnitudes of age differences in physical
functioning were comparable across the two models).
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TABLE 3 | Standardized factors loading, standard errors, and significance for the measurement model of the EORTC QLQ-C30.
Items PF RF PA FA NV CF EF SF QL
i1 0.63(0.06)∗∗∗
i2 0.68(0.06)∗∗∗
i3 0.51(0.07)∗∗∗
i4 0.55(0.07)∗∗∗
i5 0.17(0.07)∗
i6 0.75(0.05)∗∗∗
i7 0.62(0.07)∗∗∗
i9 0.65(0.06)∗∗∗
i19 0.75(0.06)∗∗∗
i10 0.55(0.06)∗∗∗
i12 0.66(0.06)∗∗∗
i18 0.65(0.06)∗∗∗
i14 0.40(0.17)∗
i15 0.13(0.12)
i20 0.47(0.09)∗∗∗
i25 0.36(0.09)∗∗∗
i21 0.60(0.06)∗∗∗
i22 0.53(0.08)∗∗∗
i23 0.54(0.08)∗∗∗
i24 0.64(0.08)∗∗∗
i26 0.51(0.08)∗∗∗
i27 0.67(0.07)∗∗∗
i29 0.92(0.07)∗∗∗
i30 1.08(0.07)∗∗∗
PF, physical functioning; RF, role functioning; PA, pain; FA, fatigue; NV, nausea and vomiting; CF, cognitive functioning; EF, emotional functioning; SF, social functioning;
QL, overall health and quality of life. ∗p < 0.05 and ∗∗∗p < 0.001.
TABLE 4 | Correlations (and their significance) among the nine latent dimensions
of the EORTC QLQ-C30.
PF RF PA FA NV CF EF SF QL
PF –
RF 0.77∗∗∗ –
PA 0.54∗∗∗ 0.71∗∗∗ –
FA 0.85∗∗∗ 0.76∗∗∗ 0.63∗∗∗ –
NV 0.34∗∗∗ 0.43∗ 0.46∗∗∗ 0.51∗∗∗ –
CF 0.51∗∗∗ 0.48∗∗∗ 0.29∗∗ 0.59∗∗∗ 0.30 –
EF 0.50∗∗∗ 0.52∗∗∗ 0.45∗∗∗ 0.62∗∗∗ 0.29∗ 0.41∗∗ –
SF 0.50∗∗∗ 0.54∗∗∗ 0.37∗∗∗ 0.51∗∗∗ 0.08 0.50∗∗∗ 0.46∗∗∗ –
QL −0.67∗∗∗−0.72∗∗∗−0.57∗∗∗−0.68∗∗∗−0.24∗ −0.51∗∗∗−0.42∗∗∗−0.43∗∗∗ –
PF, physical functioning; RF, role functioning; PA, pain; FA, fatigue; NV, nausea and
vomiting; CF, cognitive functioning; EF, emotional functioning; SF, social functioning;
QL, overall health and quality of life. ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001.
DISCUSSION
This study represents an evaluation of the dimensionality and
measurement invariance of the Italian version of the EORTC
QLQ-C30 in a sample of patients with lung cancer who
underwent lobectomy surgery. Our results demonstrated the
validity of the factor structure proposed by Costa et al. (2015)
and thus suggested that the EORTC QLQ-C30 could be used
as a valid measure of QoL in lung cancer patients undergoing
lobectomy. In a previous study, Costa et al. (2015) proposed and
supported this measurement model in a sample of cancer patients
coming from 14 countries all over the World and considering all
the types of cancer (breast, colorectal, gynecological, head and
neck, lung, esophagus/stomach, and prostate cancer). Compared
to a previous trial on lung cancer patients assessing the
changes in QoL over time (Pompili et al., 2018), this study
represents the first attempt on an Italian sample to evaluate
the dimensionality and interindividual differences of patients’
QoL with different sociodemographic and clinical characteristics.
Another study (Maringwa et al., 2011) analyzed previously DIF
on advanced cancer patients, while the present validation article
was conducted on lung cancer patients with a primitive diagnosis.
The questionnaire comprises nine different dimensions. While
one factor assesses “overall health and health-related QoL,”
the remaining eight factors measure distinct symptoms and
functioning, namely nausea/vomiting, pain, fatigue for the
symptoms’ subscales, and physical, role, emotional, cognitive,
and social functioning for the functioning subscales. All the
nine subscales were significantly and strongly loaded by their
relative items. The only exception was the nausea and vomiting
dimension: one out of its two items exhibited a non-significant
and very low loading on its factor. Further research is needed
to better assess the validity of this subscale in evaluating
symptoms of nausea and vomiting in lung cancer patients and,
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if necessary, to develop more reliable items to evaluate this kind
of adverse events.
Moreover, this study is the first one to evaluate the
psychometric properties of the Italian version of the EORTC
QLQ-C30 in lung cancer patients and assess its measurement
invariance and DIF due to age, gender, and robot-assisted
versus not robot-assisted surgery. The presence of measurement
invariance is one of the necessary steps in efficient and reliable
evaluation of interindividual differences in QoL within samples
of lung cancer patients and it represents a prerequisite to validly
compare levels of overall health across patients of different
genders and genders undergoing lobectomy with or without
robot-assisted surgery.
Our main results attested that only one item displayed a trivial
DIF. Specifically, compared to younger patients, the elderly were
more likely to endorse Item 1 (i.e., “Do you have any trouble
doing strenuous activities, like carrying a heavy shopping bag or a
suitcase?”) on a four-point scale (i.e., 1 = “Not at all”; 2 = “A little”;
3 = “Quite a bit”; and 4 = “Very much”). However, the magnitude
of this DIF was very small.
Finally, the last step in the evaluation of DIF involved the
assessment of mean differences of nine latent scores of QoL
across patients of different gender, varying age, and underwent
robot-assisted or traditional surgery. The main aim of this
analysis was to ascertain whether not controlling for DIF may
lead to consequences for the assessment of QoL (i.e., mean
differences in QoL differ when controlling or not controlling
or DIF). These results highlighted that the DIF had only an
irrelevant effect on the estimation of differences in latent means
of QoL among patients. Accidentally, the results coming from
this last step also highlighted that younger patients displayed
higher levels of physical functioning than elderly ones and that
robot-assisted surgery may promote better QoL 1 month after
surgery. Specifically, compared to patients undergoing traditional
surgery, people treated with robot-assisted surgery displayed
lower pain, nausea and vomiting, as well as better physical, role,
cognitive, and social functioning. This latter result is consistent
with empirical evidence showing that lung cancer patients treated
with robotic thoracic surgery reported a reduced postoperative
pain and complications, fewer functional impairments, and a
lower need of blood transfusions (Cheng et al., 2007; Nasir
et al., 2014). However, it’s noteworthy that the main aim of this
analysis was to assess the magnitude and the influence of DIF
on mean differences of the nine latent scores of QoL; we did
not aim at assessing differences due to age, gender, and type of
surgery on patients’ QoL. Moreover, since we did not balance
the baseline characteristics (i.e., QoL itself) between patient
underwent robot-assisted or traditional surgery, these results may
not be interpreted in a casual way.
Current results may be considered in light of some main
limitations. Specifically, it was not possible to test convergent
and/or divergent validity of the EORTC QLQ-C30 due to a lack of
other self-report measures of patients’ well-being. Nevertheless,
a previous Italian validation of the questionnaire reported a
substantial convergent validity (Apolone et al., 1998), even
though not in lung cancer patients. Finally, these statistical
analyses must be taken with caution due to the relatively small
sample size. Specifically, as highlighted by Kline (2015), the
median of typical sample sizes in structural equation modeling
studies is about 200 cases. Thus, our sample size of 167 lung
cancer patients is slightly below this common standard. However,
lower sample sizes are commonly recruited when the specific
population being studied is restricted in size and it is difficult
to reach higher sample sizes (Kline, 2015). Thus, while the
low sample size may represent a limit of our study, this size
is a direct consequence of our target population. Because of
this small sample, structural invariance of the EORTC QLQ-
C30 was assessed by performing MIMIC model and DIF
analysis which, compared to MCFA, permit to better test
measurement invariance even with small sample size. Future
research collecting larger samples would be needed to further
assess the factor structure of the EORTC QLQ-C30 in lung
cancer patients underwent lobectomy with or without robot-
assisted surgery.
Despite these limitations, our findings attested the goodness
of the nine-factor structure of the Italian version of the
EORTC QLQ-C30 in lung cancer patients and its measurement
invariance in assessing QoL in patients with varying ages genders
undergoing lobectomy with or without robot-assisted surgery.
This is also the first study validating a QoL questionnaire on
lung cancer patients. In fact, other scales have not been already
validated among Italian lung cancer samples. Additionally,
the EORTC QLQ-C30 assesses more dimensions related to
a cancer diagnosis than other questionnaires. As a practical
consequence, we advise that nine distinct scores of overall
health, pain, fatigue, nausea/vomiting, physical, social, role,
emotional, and cognitive functioning should be computed for
evaluating lung cancer patients’ QoL in future research and
clinical practice. The valid and reliable assessment of adverse
events and functioning in lung cancer patients is a relevant and
prognostic factor in patient’s recovery. In fact, patient survival
is highly affected by treatment side-effects such as fatigue,
loss of appetite, dyspnea, and coughing, as well as physical,
psychological, cognitive, and social functioning (Efficace et al.,
2006; Braun et al., 2011; Polanski et al., 2016). The EORTC
QLQ-C30 may help healthcare stakeholders in measuring and
monitoring QoL in both clinical and research fields. In particular,
QoL in lung cancer has been studied to understand patients’
health status during processes aimed to stop smoking and
how it may influence patients’ preferences in medical decision-
making. It was also used to better investigate possible long-
term effects of rumination on patients’ recovery and well-
being (Gorini et al., 2018; Masiero et al., 2019). In a patient-
centered approach, the measurement of QoL would be also
important to assess how individual differences and cognitive
processes may influence patient well-being in different medical
conditions (Pravettoni and Gorini, 2011; Cutica et al., 2014;
Arnaboldi et al., 2015).
CONCLUSION
In conclusion, the EORTC QLQ-C30 is a useful and valid
self-report tool and it can be used to assess interindividual
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differences of QoL in lung cancer patients in both clinical and
research contexts.
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